UCL is launching a major new initiative called TINs Industry Club, an opportunity for industry partners to engage the UCL Therapeutic Innovation Networks (TINs) to identify & address company R&D challenges, and to hear the latest UCL research for potential co-development. In this webinar, we showcased six areas of strength for the therapeutic modality Small Molecules that we think are ripe for collaboration.

9

5/23/2024

In this event, we will explore the therapeutic applications of these molecules with speakers from UCL and Imperial College London. Speakers: Prof David Selwood (Professor of Biological and Medical Chemistry at the Wolfson Institute for Biomedical Research, UCL) - Cellular degradation of host proteins gives potent antivirals Prof Edward Tate (Professor of Chemical Biology at the Department of Chemistry, Imperial College London) - Approaches to modulate PROTAC function Prof Robin Ketteler (Professor of Translational Cell Biology at Laboratory for Molecular Cell Bio, UCL) - On AUTACs Dr Robert Sellar (Senior Clinical Research Fellow at the Cancer Institute, UCL)

119

6/8/2021

the Small Molecules TIN (Chaired by Prof Matthew Todd) highlight UCL's capabilities in viral drug discovery, including what platforms are currently operating and how to access them, as well as outlining collaboration opportunities with UCL researchers. The speakers will also present recent research from the Small Molecules TIN. Through this event, we hope to stimulate new collaborative possibilities between scientists from different disciplines, therefore in addition to the short talks highlighted below, there may also be small group discussions. To keep updated with activities and opportunities from the Small Molecules TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter

35

3/10/2021

The Small Molecules TIN (Chaired by Prof Matthew Todd) will look at two technology platforms available at UCL for in vivo screening of small molecules. The speakers will showcase successful collaborations in drug discovery and explain how their projects have been funded. Agenda: Introduction - Prof Matthew Todd (School of Pharmacy, TIN co-chair). Target-based and phenotypic drug screening in Caenorhabditis elegans - Prof David Sattelle (Respiratory Medicine). Behavioural screening for neuroactive drugs in zebrafish - Dr Jason Rihel (Department of Cell and Developmental Biology). High-throughput automated drug screening in live zebrafish to discover novel therapeutics for MDS and AML - Dr Beth Payne (Cancer Institute). To keep updated with activities and opportunities from the Small Molecules TIN, subscribe to the TINs newsletter: https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter

69

11/9/2020